LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 16

Search options

  1. Article: Sclerosing encapsulating peritonitis presenting as acute-on-chronic small-bowel obstruction in a patient with history of peritoneal carcinomatosis.

    Hajjar, Roy / Debroux, Éric / Richard, Carole / Plasse, Marylène / Loungnarath, Rasmy

    Journal of surgical case reports

    2018  Volume 2018, Issue 4, Page(s) rjy082

    Abstract: Sclerosing encapsulating peritonitis (SEP) is a whitish fibrous envelope that encapsulates intra-abdominal peritonealized organs. Although it pathophysiology is not well understood, several possible causes have been reported in the literature, including ... ...

    Abstract Sclerosing encapsulating peritonitis (SEP) is a whitish fibrous envelope that encapsulates intra-abdominal peritonealized organs. Although it pathophysiology is not well understood, several possible causes have been reported in the literature, including peritoneal dialysis, past abdominal surgeries, peritonitis, beta-blockers and peritoneal carcinomatosis (PC). Some idiopathic cases, with no apparent causes, were described. We present a SEP case in a 43-year-old woman with a surgical history of pancreatic and liver resection for metastatic pseudopapillary pancreatic tumor, followed by several peritonectomies for PC. She was admitted for acute-on-chronic small-bowel obstruction that did not resolve with conservative management. Surgical exploration revealed a fibrous sheath covering the small-bowel. Extensive dissection, along with small-bowel segmental resection and anastomosis, was performed. The specimen was cancer-free. The mechanism through which SEP develops in certain surgical patients is still unknown. This report presents a case of successful surgical management and a review of the literature.
    Language English
    Publishing date 2018-04-24
    Publishing country England
    Document type Case Reports
    ISSN 2042-8812
    ISSN 2042-8812
    DOI 10.1093/jscr/rjy082
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy.

    Henault, David / Stephen, David / St-Hilaire, Pierre-Antoine / Messaoudi, Nouredin / Vandenbroucke-Menu, Franck / Simoneau, Eve / Rong, Zhixia / Plasse, Marylène / Létourneau, Richard / Roy, André / Dagenais, Michel / Lapointe, Réal / Nguyen, Bich / Mes-Masson, Anne-Marie / Soucy, G / Turcotte, Simon

    Oncoimmunology

    2023  Volume 12, Issue 1, Page(s) 2253642

    Abstract: In colorectal cancer liver metastases (CRLM), the density of tumor-infiltrating lymphocytes, the expression of class I major histocompatibility complex (MHC-I), and the pathological response to preoperative chemotherapy have been associated with ... ...

    Abstract In colorectal cancer liver metastases (CRLM), the density of tumor-infiltrating lymphocytes, the expression of class I major histocompatibility complex (MHC-I), and the pathological response to preoperative chemotherapy have been associated with oncological outcomes after complete resection. However, the prognostic significance of the heterogeneity of these features in patients with multiple CRLMs remains under investigation. We used a tissue microarray of 220 mismatch repair-gene proficient CRLMs resected in 97 patients followed prospectively to quantify CD3
    MeSH term(s) Humans ; Liver Neoplasms/drug therapy ; Liver Neoplasms/surgery ; Lymphocytes, Tumor-Infiltrating ; Colorectal Neoplasms
    Language English
    Publishing date 2023-09-14
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2645309-5
    ISSN 2162-402X ; 2162-402X
    ISSN (online) 2162-402X
    ISSN 2162-402X
    DOI 10.1080/2162402X.2023.2253642
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience.

    Nassabein, Rami / Mansour, Laura / Richard, Corentin / Vandenbroucke-Menu, Franck / Aubin, Francine / Ayoub, Jean-Pierre / Dagenais, Michel / Lapointe, Real / Letourneau, Richard / Plasse, Marylène / Roy, André / Turcotte, Simon / Tehfe, Mustapha

    Current oncology (Toronto, Ont.)

    2021  Volume 28, Issue 3, Page(s) 1899–1908

    Abstract: Surgery is the only potential curative option of CRLM if resectable. The curative approach in patients over 70 years old is challenging mainly because of comorbidities and other geriatric syndromes. Herein, we report outcomes of older patients with ... ...

    Abstract Surgery is the only potential curative option of CRLM if resectable. The curative approach in patients over 70 years old is challenging mainly because of comorbidities and other geriatric syndromes. Herein, we report outcomes of older patients with resectable CRLM in our center. We retrospectively analyzed characteristics and outcomes of older patients with CRLM operated at "Centre Hospitalier de l'Université de Montréal" (CHUM) between 2010 and 2019. We identified 210 patients aged ≥70 years with a median age of 76 (range: 70-85). CRLM were synchronous in 56% of patients. Median disease-free survival (DFS) was 41.3 months. Median overall survival (OS) was 62.2 months and estimated 5-year survival rate was 51.5% similar to those of younger counterparts. Patients with metachronous CRLM had a trend to a higher OS compared to those with synchronous disease (67.2 vs. 58.7 months;
    MeSH term(s) Aged ; Colorectal Neoplasms ; Disease-Free Survival ; Hepatectomy ; Humans ; Liver Neoplasms/surgery ; Retrospective Studies
    Language English
    Publishing date 2021-05-18
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 1236972-x
    ISSN 1718-7729 ; 1198-0052
    ISSN (online) 1718-7729
    ISSN 1198-0052
    DOI 10.3390/curroncol28030176
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns.

    Messaoudi, Nouredin / Henault, David / Stephen, David / Cousineau, Isabelle / Simoneau, Eve / Rong, Zhixia / Létourneau, Richard / Plasse, Marylène / Dagenais, Michel / Roy, André / Lapointe, Réal / Vandenbroucke-Menu, Franck / Kunda, Rastislav / Ysebaert, Dirk / Soucy, Geneviève / Stagg, John / Vermeulen, Peter / Turcotte, Simon

    British journal of cancer

    2022  Volume 126, Issue 9, Page(s) 1329–1338

    Abstract: Background: After resection, colorectal cancer liver metastases (CRLM) surrounded by a desmoplastic rim carry a better prognosis than the metastases replacing the adjacent liver. However, these histopathological growth patterns (HGPs) are insufficient ... ...

    Abstract Background: After resection, colorectal cancer liver metastases (CRLM) surrounded by a desmoplastic rim carry a better prognosis than the metastases replacing the adjacent liver. However, these histopathological growth patterns (HGPs) are insufficient to guide clinical decision-making. We explored whether the adaptive immune features of HGPs could refine prognostication.
    Methods: From 276 metastases resected in 176 patients classified by HGPs, tissue microarrays were used to assess intratumoral T cells (CD3), antigen presentation capacity (MHC class I) and CD73 expression producing immunosuppressive adenosine. We tested correlations between these variables and patient outcomes.
    Results: The 101 (57.4%) patients with dominant desmoplastic HGP had a median recurrence-free survival (RFS) of 17.1 months compared to 13.3 months in the 75 patients (42.6%) with dominant replacement HGP (p = 0.037). In desmoplastic CRLM, high vs. low CD73 was the only prognostically informative immune parameter and was associated with a median RFS of 12.3 months compared to 26.3, respectively (p = 0.010). Only in dominant replacement CRLM, we found a subgroup (n = 23) with high intratumoral MHC-I expression but poor CD3
    Conclusions: Combining the assessments of HGP and adaptive immune features in resected CRLM could help identify patients at risk of early recurrence.
    MeSH term(s) Colorectal Neoplasms/pathology ; Hepatectomy ; Humans ; Liver Neoplasms/pathology ; Prognosis
    Language English
    Publishing date 2022-01-03
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80075-2
    ISSN 1532-1827 ; 0007-0920
    ISSN (online) 1532-1827
    ISSN 0007-0920
    DOI 10.1038/s41416-021-01667-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Effect of intraoperative hypovolemic phlebotomy on transfusion and clinical outcomes in patients undergoing hepatectomy: a retrospective cohort study.

    Al Khaldi, Maher / Gryspeerdt, Filip / Carrier, François Martin / Bouchard, Claudia / Simoneau, Ève / Rong, Zhixia / Plasse, Marylène / Létourneau, Richard / Dagenais, Michel / Roy, André / Lapointe, Réal / Massicotte, Luc / Vandenbroucke-Menu, Franck / Rioux-Massé, Benjamin / Turcotte, Simon

    Canadian journal of anaesthesia = Journal canadien d'anesthesie

    2021  Volume 68, Issue 7, Page(s) 980–990

    Abstract: Background: There is no consensus on how to best achieve a low central venous pressure during hepatectomy for the purpose of reducing blood loss and red blood cell (RBC) transfusions. We analyzed the associations between intraoperative hypovolemic ... ...

    Title translation Effet de la phlébotomie hypovolémique peropératoire sur la transfusion et les résultats cliniques des patients subissant une hépatectomie : une étude de cohorte rétrospective.
    Abstract Background: There is no consensus on how to best achieve a low central venous pressure during hepatectomy for the purpose of reducing blood loss and red blood cell (RBC) transfusions. We analyzed the associations between intraoperative hypovolemic phlebotomy (IOHP), transfusions, and postoperative outcomes in cancer patients undergoing hepatectomy.
    Methods: Using surgical and transfusion databases of patients who underwent hepatectomy for cancer at one institution (11 January 2011 to 22 June 2017), we retrospectively analyzed associations between IOHP and RBC transfusion on the day of surgery (primary outcome), and with total perioperative transfusions, intraoperative blood loss, and postoperative complications (secondary outcomes). We fitted logistic regression models by inverse probability of treatment weighting to adjust for confounders and reported adjusted odds ratio (aOR).
    Results: There were 522 instances of IOHP performed during 683 hepatectomies, with a mean (standard deviation) volume of 396 (119) mL. The IOHP patients had a 6.9% transfusion risk on the day of surgery compared with 12.4% in non-IOHP patients (aOR, 0.53; 95% confidence interval [CI], 0.29 to 0.98; P = 0.04). Total perioperative RBC transfusion tended to be lower in IOHP patients compared with non-IOHP patients (14.9% vs 22.4%, respectively; aOR, 0.72; 95% CI, 0.44 to 1.16; P = 0.18). In patients with a predicted risk of ≥ 47.5% perioperative RBC transfusion, 24.6% were transfused when IOHP was used compared with 56.5% without IOHP. The incidence of severe postoperative complications (Clavien-Dindo scores ≥ 3) was similar in patients whether or not IOHP was performed (15% vs 16% respectively; aOR, 0.97; 95% CI, 0.53 to 1.54; P = 0.71).
    Conclusions: The use of IOHP during hepatectomy was associated with less RBCs transfused on the same day of surgery. Trials comparing IOHP with other techniques to reduce blood loss and transfusion are needed in liver surgery.
    MeSH term(s) Blood Transfusion ; Hepatectomy ; Humans ; Hypovolemia/epidemiology ; Phlebotomy ; Retrospective Studies
    Language English
    Publishing date 2021-05-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 91002-8
    ISSN 1496-8975 ; 0832-610X
    ISSN (online) 1496-8975
    ISSN 0832-610X
    DOI 10.1007/s12630-021-01958-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Prognostic value of CD73 expression in resected colorectal cancer liver metastasis.

    Messaoudi, Nouredin / Cousineau, Isabelle / Arslanian, Elizabeth / Henault, David / Stephen, David / Vandenbroucke-Menu, Franck / Dagenais, Michel / Létourneau, Richard / Plasse, Marylène / Roy, André / Lapointe, Réal / Ysebaert, Dirk / Trudel, Dominique / Soucy, Geneviève / Stagg, John / Turcotte, Simon

    Oncoimmunology

    2020  Volume 9, Issue 1, Page(s) 1746138

    Abstract: Immune checkpoint blockade has not yet been effective in patients with mismatch repair proficient metastatic colorectal cancer. Targeting immunosuppressive metabolic pathways is being explored as a new immunotherapeutic approach. We assessed whether CD73, ...

    Abstract Immune checkpoint blockade has not yet been effective in patients with mismatch repair proficient metastatic colorectal cancer. Targeting immunosuppressive metabolic pathways is being explored as a new immunotherapeutic approach. We assessed whether CD73, the rate limiting enzyme that catalyzes the degradation of extracellular AMP into immunosuppressive adenosine, could be an immunological determinant of colorectal liver metastases (CRLMs). By immunofluorescence on tissue microarrays, intratumoral CD73 expression (tCD73) was analyzed in 391 CRLMs resected in 215 patients, and soluble CD73 (sCD73) was measured by ELISA in the pre-operative serum of 193 patients. High tCD73 was associated with worse pathological features, such as multiple and larger CRLMs, and poorer pathologic response to pre-operative chemotherapy. The median time to recurrence and disease-specific survival after CRLM resection was significantly shorter in patients with high tCD73 (11.0 and 46.4 months, respectively) compared with low tCD73 (19.0 and 61.5 months, respectively). tCD73 was strongly associated with patient outcomes independently of clinicopathological variables. sCD73 did not correlate with tCD73. Patients with high levels of sCD73 also had shorter disease-specific survival. Our results suggested that CD73 in CRLMs may be prognostically informative and may help select patients more likely to respond to adenosine pathway blocking agents.
    MeSH term(s) Humans ; Liver Neoplasms/surgery ; Neoplasm Recurrence, Local ; Prognosis ; Rectal Neoplasms
    Language English
    Publishing date 2020-04-23
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2645309-5
    ISSN 2162-402X ; 2162-4011
    ISSN (online) 2162-402X
    ISSN 2162-4011
    DOI 10.1080/2162402X.2020.1746138
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Answer to case of the month #162. Emphysematous infection of the liver parenchyma.

    Létourneau-Guillon, Laurent / Audet, Pascale / Plasse, Marylène / Lepanto, Luigi

    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes

    2010  Volume 61, Issue 2, Page(s) 117–119

    MeSH term(s) Contrast Media ; Diagnosis, Differential ; Emphysema/diagnostic imaging ; Emphysema/microbiology ; Fatal Outcome ; Hepatitis/diagnostic imaging ; Hepatitis/microbiology ; Humans ; Liver Function Tests ; Male ; Middle Aged ; Postoperative Complications/diagnostic imaging ; Postoperative Complications/microbiology ; Tomography, X-Ray Computed
    Chemical Substances Contrast Media
    Language English
    Publishing date 2010-03-18
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 418190-6
    ISSN 0846-5371 ; 0008-2902
    ISSN 0846-5371 ; 0008-2902
    DOI 10.1016/j.carj.2009.10.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study.

    Collin, Yves / Paré, Alex / Belblidia, Assia / Létourneau, Richard / Plasse, Marylène / Dagenais, Michel / Turcotte, Simon / Martel, Guillaume / Roy, André / Lapointe, Real / Vandenbroucke-Menu, Frank

    International journal of surgery (London, England)

    2018  Volume 61, Page(s) 42–47

    Abstract: Background: Previous studies comparing the survival outcomes of liver resections with and without preoperative portal vein embolization (PVE) for colorectal liver metastases (CLM) have linked PVE to higher rate of tumor progression, lower overall ... ...

    Abstract Background: Previous studies comparing the survival outcomes of liver resections with and without preoperative portal vein embolization (PVE) for colorectal liver metastases (CLM) have linked PVE to higher rate of tumor progression, lower overall survival (OS) and lower disease-free survival (DFS). The lack of adjusted models to compare these outcomes is a limitation of these studies since patients requiring PVE may differ significantly from the ones receiving upfront surgery.
    Materials and methods: Prospective cohort study of 128 patients undergoing CLM resection. The OS analysis followed an intent-to-treat (ITT) approach. The adjusted impact of PVE on OS and DFS was evaluated using multivariate Cox regression models.
    Results: Seventy-one patients underwent PVE before attempting a liver resection while 57 received upfront surgery (NoPVE). All NoPVE patients were resected while 14 PVE participants (19.7%) were not operated (tumor progression = 9/14). PVE patients had a significantly higher preoperative lesions count (3 [1.75-4] vs 1 [1-2.5]; p < 0.001), a higher prevalence of bilateral metastases (23.5% vs 8.8, p = 0.028) and a higher count of neo-adjuvant chemotherapy cycles compared to NoPVE patients. The OS of PVE patients was similar to NoPVE participants (44.7 months [26.9-69.5] vs 49.0 [24.9-64.8], p = 0.761). The DFS of resected PVE patients was higher than NoPVE patients (33.2 months [10.7-54.6] vs 23.4 months [14.1-58.1], p = 0.991). In the adjusted models, preoperative lesions count was the only significant predictor of overall mortality (HR+IC
    Conclusion: In the context of CLM, patients requiring PVE differ significantly from patients receiving upfront surgery. This confirms the need for adjusted models when comparing the clinical outcomes of both groups. Our adjusted analysis suggests that PVE is not a significant predictor of a lower OS or DFS. PVE allowed the resection of 80% of participants with initially unresectable CLM.
    Institutional protocol number: 12.106 STUDY REGISTRATION NUMBER: NCT03168230.
    MeSH term(s) Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cohort Studies ; Colorectal Neoplasms/mortality ; Colorectal Neoplasms/pathology ; Colorectal Neoplasms/therapy ; Embolization, Therapeutic/adverse effects ; Embolization, Therapeutic/methods ; Female ; Hepatectomy/adverse effects ; Hepatectomy/methods ; Humans ; Liver Neoplasms/mortality ; Liver Neoplasms/secondary ; Liver Neoplasms/therapy ; Male ; Middle Aged ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/etiology ; Portal Vein/surgery ; Postoperative Complications ; Preoperative Care/methods ; Prospective Studies ; Risk Factors ; Survival Analysis ; Treatment Outcome
    Language English
    Publishing date 2018-12-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 2212038-5
    ISSN 1743-9159 ; 1743-9191
    ISSN (online) 1743-9159
    ISSN 1743-9191
    DOI 10.1016/j.ijsu.2018.11.029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Impact of localized congestion related to venous deprivation after hepatectomy.

    Scatton, Olivier / Plasse, Marylène / Dondero, Fédérica / Vilgrain, Valérie / Sauvanet, Alain / Belghiti, Jacques

    Surgery

    2008  Volume 143, Issue 4, Page(s) 483–489

    Abstract: Objective: We sought to assess the impact of localized venous congestion related to venous deprivation on liver function recovery and regeneration after hepatectomy, using the living donation model. Harvesting the middle hepatic vein (MHV) optimizes the ...

    Abstract Objective: We sought to assess the impact of localized venous congestion related to venous deprivation on liver function recovery and regeneration after hepatectomy, using the living donation model. Harvesting the middle hepatic vein (MHV) optimizes the venous drainage of right grafts but could lead to donor segment IV congestion.
    Methods: In a series of 44 donors, 25 underwent right liver harvesting without the MHV and 19 with the MHV. The venous drainage anatomy of segment IV was defined as type I if exclusive through the MHV and type II if shared through the left hepatic vein. We prospectively studied the occurrence, magnitude (global or partial), and regeneration impacts of segment IV congestion on computed tomography (CT) performed 1 week and 1 month after surgery.
    Results: Early postoperative CT showed that segment IV congestion was never observed in the group without MHV harvesting, and it was present in 16 (84%) of 19 donors with MHV harvesting. Segment IV congestion was global in 9 donors, including 7 with type I anatomy. Postoperative data comparing data of the 9 donors with global congestion (GC) with other donors showed that the prothrombin time was significantly (P < .05) lower on day 1 and 5 (53% vs 63% and 76% vs 86%, respectively), and segment IV regeneration rate was lower (3.6% vs 11%) in the former group. However, a higher regeneration rate of segments II and III in the GC group (11.8% vs 3.6%) resulted in a similar regeneration rate of the remnant liver 1 month after hepatectomy (59.4 +/- 12% vs 57.8 +/- 12.4%).
    Conclusions: Postoperative localized venous congestion is highly related to venous anatomy and affects both early postoperative liver function and regeneration rate. Based on this living donor model, we suggest that venous anatomy evaluation of the future remnant liver parenchyma be performed systematically before extended resection of living small or diseased remnants.
    MeSH term(s) Adolescent ; Adult ; Hepatectomy ; Hepatic Veins/surgery ; Hepatic Veins/transplantation ; Humans ; Liver/blood supply ; Liver Regeneration/physiology ; Liver Transplantation/adverse effects ; Living Donors ; Middle Aged ; Tomography, X-Ray Computed ; Venous Insufficiency/diagnostic imaging ; Venous Insufficiency/etiology
    Language English
    Publishing date 2008-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 202467-6
    ISSN 1532-7361 ; 0039-6060
    ISSN (online) 1532-7361
    ISSN 0039-6060
    DOI 10.1016/j.surg.2007.11.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Effect of N-acetylcysteine on blood and tissue lipid peroxidation in lipopolysaccharide-induced obstructive jaundice.

    Caglikulekci, Mehmet / Dirlik, Musa / Pata, Cengiz / Plasse, Marylene / Tamer, Lulufer / Ogetman, Zekai / Ercan, Bahadir

    Journal of investigative surgery : the official journal of the Academy of Surgical Research

    2006  Volume 19, Issue 3, Page(s) 175–184

    Abstract: In obstructive jaundice, free radical production is increased and antioxidative activity is reduced. N-Acetylcysteine (NAC) has a beneficial effect with anti-inflammatory and antioxidant activity, acting as a free radical scavenger. NAC inhibits ... ...

    Abstract In obstructive jaundice, free radical production is increased and antioxidative activity is reduced. N-Acetylcysteine (NAC) has a beneficial effect with anti-inflammatory and antioxidant activity, acting as a free radical scavenger. NAC inhibits inducible nitric oxide synthase, suppresses cytokine expression/release, and inhibits adhesion molecule expression and nuclear factor kappa B. The aim of this study was to investigate the effects of NAC on liver/renal tissue and serum lipid peroxidation in lipopolysaccharide (LPS)-induced obstructive jaundice. We randomized 60 rats into 6 groups: group 1, Sham; group 2, obstructive jaundice (OJ) induced after bile-duct ligation; group 3, OJ + NAC (100 mg kg- 1 subcutaneously); group 4, OJ + LPS (10 mg kg-1); group 5, OJ + NAC + LPS; and group 6, OJ + LPS + NAC. For each group, the biochemical markers of lipid peroxidation and the antioxidant products were measured in serum and liver/renal tissue after sacrifice. Almost all lipid peroxidation products levels were increased and antioxidant products levels were decreased in groups who received LPS (groups 4, 5, and 6), but the effect was less remarkable when NAC was administered before LPS (group 5). The same trend was seen for groups with OJ +/- LPS who did not received NAC or received it after induced toxemia (groups 2, 4, and 6) as compared to groups 1 and 3. Moreover, in the case of OJ + LPS, rats treated with NAC before LPS (group 5) had lower lipid peroxidation products levels and higher antioxidant products levels as compared to those who did not received NAC (group 4). This phenomenon was not reproducible with NAC administered after LPS (group 6). Thus, results of this study showed that NAC prevents the deleterious effects of LPS in obstructive jaundice by reducing lipid peroxidation in serum and liver/renal tissue if administered before LPS. Nonetheless, NAC failed to prevent the lipid peroxidation in the case of established endotoxemia in obstructive jaundice.
    MeSH term(s) Acetylcysteine/pharmacology ; Animals ; Ascorbic Acid/blood ; Bile Ducts ; Erythrocytes/metabolism ; Free Radical Scavengers/pharmacology ; Glutathione/metabolism ; Jaundice, Obstructive/chemically induced ; Jaundice, Obstructive/drug therapy ; Jaundice, Obstructive/metabolism ; Kidney/metabolism ; Ligation ; Lipid Peroxidation/drug effects ; Lipopolysaccharides/pharmacology ; Liver/metabolism ; Male ; Malondialdehyde/blood ; Oxidative Stress/drug effects ; Rats ; Rats, Wistar ; Sodium-Potassium-Exchanging ATPase/metabolism ; Thiobarbituric Acid Reactive Substances/metabolism
    Chemical Substances Free Radical Scavengers ; Lipopolysaccharides ; Thiobarbituric Acid Reactive Substances ; Malondialdehyde (4Y8F71G49Q) ; Sodium-Potassium-Exchanging ATPase (EC 3.6.3.9) ; Glutathione (GAN16C9B8O) ; Ascorbic Acid (PQ6CK8PD0R) ; Acetylcysteine (WYQ7N0BPYC)
    Language English
    Publishing date 2006-05-23
    Publishing country United States
    Document type Journal Article
    ZDB-ID 639444-9
    ISSN 1521-0553 ; 0894-1939
    ISSN (online) 1521-0553
    ISSN 0894-1939
    DOI 10.1080/08941930600674702
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top